Docomed.
Request a demo

Cardiovascular intelligence · out of hospital

Reveal hidden cardiovascular risk before it becomes a crisis.

Docomed brings diagnostic-quality cardiac assessment to the point of care and the patient’s home, a 30-second test that helps clinicians act earlier, keep patients out of hospital, and change where heart failure is found.

From silent risk to earlier action, one heartbeat at a time.

I'm a clinician I'm a health system
Point-of-care screening· Remote patient monitoring

The challenge

Today's cardiovascular care is reactive by design.

Cardiovascular disease is overwhelming health systems. Care is intermittent, fragmented and reactive, and too often, deterioration is caught too late, through the most expensive door in the system.

A large patient population under rising cardiovascular pressure.
66M+
people across the US and UK living with heart disease or COPD.
#1
cause of unplanned hospital admissions and readmissions.
70–80%
of first heart-failure diagnoses are made in the acute setting, not in primary care.

Read the full challenge

The shift

Heart failure isn't hard to diagnose. The problem is the door it comes through.

A patient identified in primary care enters a planned pathway, titrated medication, scheduled follow-up, no ambulance. A patient identified in the emergency department enters through the single most expensive door in the system, with worse one-year outcomes.

Docomed moves detection upstream: from the crisis to the routine visit, from the hospital to the home.

Found earlyPrimary care. Planned pathway, managed medication, patient stays home and in work.
Found lateEmergency department. $25k–$37k first-year cost, higher mortality, avoidable admission.

Two ways in

One platform, two clinical pathways.

Whether you assess patients one visit at a time or manage risk across a population, Docomed meets care where it already happens.

For clinicians

Screen at the visit that's already happening.

Run a 30-second cardiovascular assessment during any routine appointment, no new appointment, no specialist referral. Surface silent risk in the patients already in front of you.

Explore the clinician pathway
For health systems

Monitor your highest-risk patients, continuously.

Docomed's remote monitoring tracks deterioration in comorbid, high-risk patients between visits, reducing admissions, length of stay and 30-day readmissions.

Explore the health-system pathway

The Artemis™ platform

From the body's own signals to clinical insight.

Artemis pairs a novel sensing technology with an AI diagnostic cloud and purpose-built devices, one connected platform for the clinic and the home.

A person using Docomed cardiovascular sensing technology.
Cardiox™
Body-as-sensor technology

An advanced cardiovascular sensor refined over 15 years that uses the body itself as the sensor, capturing diagnostic-quality data in seconds.

Cardiovue™
AI diagnostic cloud

An AI-enabled analytical and diagnostic SaMD cloud suite, delivering timely analysis, findings and diagnosis to clinicians.

CarePortal™
Clinic & home tablet

Cardiox™ embedded in a purpose-built handheld Android tablet, designed for patients across a wide range of abilities.

HealthHub™
Bluetooth handheld

Cardiox™ in a lower-cost, Bluetooth-enabled handheld device, the same core capability, built for reach and scale.

30-second assessmentOut-of-hospital · diagnostic-quality · AI-drivenExplore the platform

The Triple-P value

Value that lands across the system.

Earlier detection doesn’t just change a clinical outcome, it changes the economics for everyone with a stake in the patient.

A hospital representing the shift from crisis care to prevention.
Payer

Fewer admissions

50%+ fewer

hospital admissions through early detection, moving spend from the crisis to prevention.

Provider

Reduced burden

Up to 70% less

length of stay, alongside a 50%+ reduction in readmissions, freeing clinical capacity.

Patient

Caught earlier

Days, not events

early detection of cardiac and respiratory deterioration, and more time lived at home.

Evidence

Proven in real-world care.

Docomed’s approach is grounded in deployed clinical programmes, not projections.

NHS Frimley ICS · remote monitoring

~6,000 high-risk patients monitored between visits

−53.7%hospital admissions
−38.6%A&E attendances
−36.3%999 emergency calls
−26.7%outpatient appointments
AF detection · flu-vaccination clinics

851 patients assessed opportunistically

28confirmed cases of atrial fibrillation
3cases of complete heart block needing urgent care
1 vs 21strokes at two years, assessed vs comparison

See the full evidence

The team

Built by people who have done this before.

Docomed is built on a quarter-century of remote patient monitoring expertise, with proven clinical outcomes and regulatory approvals behind it. The team has taken two generations of medical devices from concept to Class IIa CE mark and commercial rollout, and is advised by leading cardiologists and primary-care physicians.

25 years in RPMClass IIa CE heritageClinical advisory board
Meet the team
25years
of cardiovascular monitoring expertise behind a single, focused platform.

See where Docomed fits in your pathway.

Whether you’re a clinician exploring point-of-care assessment or a health system planning at population scale, we’d like to show you how it works.

I'm a clinician I'm a health system